​

Omnicell (OMCL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OMCL Stock Forecast

Omnicell (OMCL) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $45.00, with a high of $55.00 and a low of $35.00. This represents a 47.35% increase from the last price of $30.54.

$25 $31 $37 $43 $49 $55 High: $55 Avg: $45 Low: $35 Last Closed Price: $30.54

OMCL Stock Rating

Omnicell stock's rating consensus is Hold, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (42.11%), 11 Hold (57.89%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 19 0 11 8 Strong Sell Sell Hold Buy Strong Buy

OMCL Price Target Upside V Benchmarks

TypeNameUpside
StockOmnicell47.35%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 12.26%

Price Target Trends

1M3M12M
# Anlaysts-14
Avg Price Target-$55.00$47.00
Last Closing Price$30.54$30.54$30.54
Upside/Downside-80.09%53.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25143--8
Sep, 25143--8
Aug, 25143--8
Jul, 25134--8
Jun, 25134--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 11, 2025Jessica TassanPiper Sandler$55.00$31.1176.79%80.09%
May 14, 2025Stan BerenshteynWells Fargo$35.00$27.4627.46%14.60%
Jan 13, 2025Stan BerenshteynWells Fargo$40.00$43.37-7.77%30.98%
Oct 31, 2024Stephanie DavisBarclays$58.00$53.059.33%89.91%
Aug 05, 2024Sean WielandPiper Sandler$61.00$40.0052.50%99.74%
Aug 02, 2024Stephanie DavisBarclays$39.00$39.22-0.56%27.70%
Nov 18, 2022J.P. Morgan$57.00$53.636.28%86.64%
Aug 08, 2022Jessica TassanPiper Sandler$150.00$109.1237.46%391.16%
Jun 16, 2022Stan BerenshteynWells Fargo$158.00$109.8243.87%417.35%
May 03, 2022Piper Sandler$162.00$114.9040.99%430.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 11, 2025Piper SandlerOverweightOverweighthold
May 23, 2025Piper SandlerOverweightOverweighthold
May 23, 2025Wells FargoOverweightOverweighthold
May 14, 2025Wells FargoEqual-WeightOverweightupgrade
Nov 11, 2024Bank of America SecuritiesNeutralNeutralhold
Oct 31, 2024Craig-HallumBuyBuyhold
Oct 31, 2024BarclaysEqual-WeightEqual-Weighthold
Oct 14, 2024Wells FargoEqual-WeightEqual-Weighthold
Oct 09, 2024BenchmarkUnderperformUnderperformhold
Sep 11, 2024KeyBancSector WeightSector Weighthold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.76$1.79$0.13$-0.45$0.27---
Avg Forecast$2.44$3.83$2.74$1.73$1.69$1.81$2.05$2.22
High Forecast$2.51$3.93$2.82$1.78$1.72$1.92$2.46$2.32
Low Forecast$2.40$3.77$2.68$1.68$1.66$1.70$1.47$2.15
Surprise %-68.85%-53.26%-95.26%-126.01%-84.02%---

Revenue Forecast

$850M $950M $1B $1B $1B $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$892.21M$1.13B$1.30B$1.15B$1.11B---
Avg Forecast$888.72M$1.13B$1.29B$1.14B$1.11B$1.16B$1.20B$1.23B
High Forecast$906.43M$1.15B$1.32B$1.15B$1.14B$1.18B$1.21B$1.24B
Low Forecast$877.18M$1.12B$1.27B$1.12B$1.08B$1.14B$1.18B$1.21B
Surprise %0.39%0.01%0.79%0.25%0.63%---

Net Income Forecast

$-50M $-10M $30M $70M $110M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$32.19M$77.85M$5.65M$-20.37M$12.53M---
Avg Forecast$27.64M$60.82M$55.16M$-20.37M$76.30M$81.86M$88.86M$100.37M
High Forecast$33.91M$72.99M$66.19M$-16.30M$77.67M$86.92M$111.08M$105.01M
Low Forecast$21.37M$48.66M$44.13M$-24.45M$74.94M$76.80M$66.65M$97.21M
Surprise %16.48%27.99%-89.76%--83.58%---

OMCL Forecast FAQ

Is Omnicell stock a buy?

Omnicell stock has a consensus rating of Hold, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 11 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Omnicell is a neutral investment for most analysts.

What is Omnicell's price target?

Omnicell's price target, set by 19 Wall Street analysts, averages $45 over the next 12 months. The price target range spans from $35 at the low end to $55 at the high end, suggesting a potential 47.35% change from the previous closing price of $30.54.

How does Omnicell stock forecast compare to its benchmarks?

Omnicell's stock forecast shows a 47.35% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (12.26%).

What is the breakdown of analyst ratings for Omnicell over the past three months?

  • October 2025: 12.50% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 12.50% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 12.50% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.

What is Omnicell’s EPS forecast?

Omnicell's average annual EPS forecast for its fiscal year ending in December 2025 is $1.81, marking a 570.37% increase from the reported $0.27 in 2024. Estimates for the following years are $2.05 in 2026, and $2.22 in 2027.

What is Omnicell’s revenue forecast?

Omnicell's average annual revenue forecast for its fiscal year ending in December 2025 is $1.16B, reflecting a 4.21% increase from the reported $1.11B in 2024. The forecast for 2026 is $1.2B, and $1.23B for 2027.

What is Omnicell’s net income forecast?

Omnicell's net income forecast for the fiscal year ending in December 2025 stands at $81.86M, representing an 553.29% increase from the reported $12.53M in 2024. Projections indicate $88.86M in 2026, and $100.37M in 2027.